Categories: Marijuana Politics

UK Government Ends Ban on Bulk Cannabis Imports

The UK government has ended a ban on bulk imports of medical cannabis to eradicate the long delays that patients have faced.

Licensed wholesalers will be able to import larger quantities of cannabis and also to hold stock for future use. The government promised that patients would now be able to receive cannabis-based medicines within days rather than months as a result of the changes.

Health Secretary Matt Hancock said the changes are “a tremendous step” towards improving patient access, but admitted the government still has a long way to go. “We need more research into the quality and safety of these medicines, and to do all we can to cut down the costs and remove barriers so that, when appropriate, patients can access it, including on the NHS,” he said.

Home Secretary Priti Patel, whose predecessor Sajid Javid legalized medical cannabis in 2018, added that she has taken swift action to allow specialist doctors to issue prescriptions for cannabis-based medicinal products in a speedier fashion.

British patients currently have to wait around two months to receive cannabis-based medicines. That is a result of the UK’s onerous regulations, which have now been lifted.

The UK’s medical cannabis sector is small for a country of its size, as doctors have only recently been permitted to actually issue prescriptions. More need to be educated about its potential benefits, but campaigners welcomed the news that the government is committed to improving research in this field.

Subscribe Now
Sign up to get Grizzle's latest news and analysis in your inbox!

Sending Message...


Britain’s first cannabis-based medicine, GW Pharma’s Epidyolex, was made available for epilepsy sufferers on Jan. 6, 2020, after the government fast-tracked it into the National Health Service. Another GW Pharma product, Sativex, has also been given the green light.

Sativex is used to ease the pain suffered by patients with multiple sclerosis. Right now they often self-medicate by purchasing cannabis on the black market.

A survey conducted by YouGov earlier this year suggested that 1.4 million Brits turn to illicit means to source marijuana in a bid to ease their pain. Roughly a fifth of MS sufferers said they self-medicate.

The UK Centre for Medical Cannabis welcomed the news. It said cost savings will be passed onto patients, making cannabis quicker to source and more affordable.

The opinions provided in this article are those of the author and do not constitute investment advice. Readers should assume that the author and/or employees of Grizzle hold positions in the company or companies mentioned in the article. For more information, please see our Content Disclaimer.

Subscribe Now
Sign up to get Grizzle's latest news and analysis in your inbox!

Sending Message...


Martin Green

Martin Green is an experienced journalist with a strong focus on the cannabis, alcohol, and gambling industries. He is particularly interested in the political issues affecting the global marijuana trade, and he has a keen focus on regulation changes and legal topics. He holds a BA English Literature, MA Creative Writing and a National Qualification in Journalism diploma. He has worked in journalism since 2009 and written for a broad range of newspapers, business titles and magazines, including The Sun, The Metro, The Journal, Livestrong, Drinks Retailing News, Harpers, Sportsbook Review, Vital Football, Essex Live and Surrey Live.

Disqus Comments Loading...
Share
Published by